Prognostic factors in Hodgkin's disease

Leukemia and Lymphoma

Volumn 45, Issue 6, 2004, Pages 1133-1139

  Provencio, Mariano ^a   España, Pilar ^a   Millán, Isabel ^a   Yebra, Miguel ^a   Sánchez, Antonio C ^a   De La Torre, Alejandro ^a   Bonilla, Félix ^a   Regueiro, Carlos A ^a   De Letona, Juan Martínez L ^a  

^a HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

Author keywords

Hodgkin's disease; Prognostic factors

Indexed keywords

BLEOMYCIN; CHLORMETHINE; DACARBAZINE; DOXORUBICIN; PREDNISONE; PROCARBAZINE; VINBLASTINE; VINCRISTINE;

ADAPTIVE BEHAVIOR; ADULT; AGE; ARTICLE; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER REGRESSION; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HODGKIN DISEASE; HUMAN; LYMPHOCYTE DEPLETION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; RECURRENCE RISK; RISK ASSESSMENT; SEX DIFFERENCE; SPLEEN DISEASE; SYMPTOM; TREATMENT OUTCOME;

ADULT; ANTINEOPLASTIC AGENTS; COMBINED MODALITY THERAPY; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; FEMALE; HODGKIN DISEASE; HUMANS; MALE; NEOPLASM STAGING; PROGNOSIS; REMISSION INDUCTION; SURVIVAL RATE; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 2342631885     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.1080/10428190310001646022     Document Type: Article

References (58)

1. Bonadonna, G., Zucali, R., Monfardini, S., et al. (1975) "Combination chemotherapy of Hodgkin's disease with adriamycin, bleomycin, vinblastine, and imidazole carboxamide versus MOPP", Cancer, 36, 252-259.
2. Provencio, M., Garcia-Lopez, F.J., Bonilla, F. and España, P. (1999) "Comparison of the long-term mortality in Hodgkin's disease patients with that of the general population", Ann. Oncol., 10, 1199-1205.
3. Hasenclever, D. and Dielh, V. (1998) "International Prognostic Factors Project on Advanced Hodgkin's disease. A prognostic score to predict tumor control in advanced Hodgkin's disease", N. Engl. J. Med., 339, 1506-1515.
4. Carbone, P.P., Kaplan, H.S., Musshoff, K., Smithers, D.W. and Tubiana, M. (1971) "Report of the Committee on Hodgkin's disease Staging Classification", Cancer Res., 31, 1860-1861.
5. Lister, T.A., Crowther, D., Sutcliffe, S.B., Glatstein, E., Canellos, G.P., Young, R.C., et al. (1989) "Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin's disease: Cotswolds meeting, J. Clin. Oncol., 7, 1630-1636.
6. De Vita, V.T. and Serpick, A. (1967) Combination chemotherapy in the treatment of advanced Hodgkin's disease (abstract ", Proc. Amer. Ass. Cancer Res., 8, 13.
7. Bonadonna, G., Zucali, R., Monfardini, S., et al. (1975) "Combination chemotherapy of Hodgkin's disease with adriamycin, bleomycin, vinblastine, and imidazole carboxamide versus MOPP", Cancer, 36, 252-259.
8. Kaplan, H.S. and Rosenberg, S.A. (1966) "Extended field radical radiotherapy in advanced Hodgkin's disease", Cancer Res., 26, 1268-1276.
9. Otero Luna, J. and Solsona, F. (1969) "La radioterapia sistémica de la Enfermedad de Hodgkin", Radiología, 66, 29-44.
10. Aragon, G. and Otero Luna, J. (1971) "La Enfermedad de Hodgkin en la infancia. Tolerancia immediate a la irradiación sistémica", Rev. Clin. Esp., 121, 561-571.
11. Urba, W.J. and Longo, D. (1992) "Hodgkin's disease", N. Engl. J. Med., 10, 678-687.
12. Dixon, D.O., McLaughlin, P., Hagemeister, F.B., Freireich, E.J., Fuller, L.M., Cabanillas, F.F., et al. (1987) "Reporting outcomes in Hodgkin's disease and lymphoma", J. Clin. Oncol., 10, 1670-1672.
13. a edición.
14. Armitage, P. and Berry, G. (1987) Statistical Methods in Medical Research. Oxford: Blackwell Scientific Publication.
15. Kaplan, E.S. and Meier, P. (1958) "Nonparametric estimation from incomplete observations", J. Am. Stat. Assoc., 53, 457-481.
16. Cox, D.R. (1972) "Regression models and life-tables", J. R. Stat. Soc. B., 34, 187-220.
17. Mantel, N. (1966) "Evaluation of survival data and two new rank order statistics arising in its consideration", Cancer Chemother. Rep., 50, 163-170.
18. Simon, R. (1986) "Confidence intervals for reporting results of clinical trial", Ann. Intern. Med., 105, 429-435.
19. Bodis, S., Henry-Amar, M., Bosq, J., Burgers, J.M., Mellink, W.A., Dietrich, P.Y., et al. (1992) "Late relapse in early-stage Hodgkin's disease patients enrolled in EORTC protocols", J. Clin. Oncol, 11, 225-232.
20. Lohri, A., Barnett, M., Fairey, R.N., O'Reilly, S.E., Phillips, G.L., Reece, D., et al. (1991) "Outcome on first relapse of Hodgkin's disease after primary chemotherapy: identification of risk factors from the British Columbia experience 1970 to 1980", Blood, 77, 2292-2298.
21. Viviani, S., Santoro, A., Negretti, A., Bonafante, V., Valagussa, P. and Bonadonna, G. (1990) "Salvage chemotherapy in Hodgkin's disease", Ann. Oncol., 1, 123-127.
22. Fiher, R.I., De Vita, V.T., Hubbard, R.N., et al. (1979) "Prolonged disease free survival in Hodgkin's disease with MOPP reinduction after first relapse", Ann. Intern. Med., 90, 761-763.
23. Bernhars, J., Fischer, R., Hübner, K., et al. (1992) "Histopathological classification of Hodgkin's lymphomas", Ann. Oncol., 3, 31-33.
24. Glaser, S.L. (1990) "Hodgkin's disease in black populations: a review of the epidemiologic literature", Semin. Oncol., 17, 643-659.
25. Gutensohn, N.M. (1982) "Social class and age at diagnosis of Hodgkin's disease. New epidemiologic evidence for the 'two-disease hypothesis"', Cancer Treat. Rep., 66, 689-695.
26. Medeiros, L.J. and Greiner, T.C. (1995) "Hodgkin's disease", Cancer, 75, 357-369.
27. Correa, P. and O'Conor, G.T. (1971) "Epidemiologic patterns of Hodgkin's disease", Int. J. Cancer, 8, 192-201.
28. Specht, L. (1991) "Prognostic factors in Hodgkin's disease", Cancer Treat. Rev., 8, 21-53.
29. Ranson, M.R., Radford, J.A., Swindell, R., et al. (1991) "An analysis of prognostic factors in stage III and IV Hodgkin's disease treated at a single centre with MVPP", Ann. Oncol., 2, 423-429.
30. Proctor, S.J., Taylor, P., Donnan, P., et al. (1991) "A numerical prognostic index for clinical use in identification of poor-risk patients with Hodgkin's disease at diagnosis. Scotland and Newcastle Lymphoma Group (SNLG) Therapy Working Party", Eur. J. Cancer, 27, 624-629.
31. Kant, J.A., Hubbard, S.M., Longo, D.L., et al. (1986) "The pathologic and clinical heterogeneity of lymphocyte-depleted Hodgkin's disease", J. Clin. Oncol., 4, 284-294.
32. Vaughan, B., MacLennan, K.A., Easterling, M.J., et al. (1983) "The prognostic significance of age in Hodgkin's disease: Examination of 1500 patients (BNLI Report No 23)", Clin. Radiol., 34, 503-506.
33. Tubiana, M., Henry-Amar, M., Van Der Werf-Messing, B., et al. (1985) "A multivariate analysis of prognostic factors in early Hodgkin's disease", Int. J. Radiat. Oncol. Biol. Phys., 11, 23-30.
34. Yancik, R., Ries, L.G. and Yates, J.W. (1986) "Ovarian cancer in the elderly: an analysis of Surveillance, Epidemiology, and End Results program data", Am. J. Obstet. Gynecol., 154, 639-647.
35. Dixon, D.O., Neilan, B., Jones, S., et al. (1986) "Effect of age on therapeutic outcome in advanced diffuse histiocytic lymphoma: The Southwest Oncology Group Experience", J. Clin. Oncol., 4, 295-305.
36. Nixon, A.J., Neuberg, D., Hayes, D.F., et al. (1994) "Relationship of patient age to pathologic features of the tumor and prognosis for patients with stage I and II breast cancer", J. Clin. Oncol., 12, 888-894.
37. Specht, L. and Nissen, N.I. (1989) "Hodgkin's disease and age", Eur. J. Haematol., 43, 127-135.
38. Walker, A., Schoenfeld, E.R., Lowman, J.T., et al. (1990) "Survival of the older patient compared with the younger patient with Hodgkin's disease. Influence of histologic type, staging, and treatment", Cancer, 65, 1635-1640.
39. Gobbi, P.G., Cavalli, C., Federico, M., et al. (1998) "Hodgkin's disease prognosis: a directly predictive equation", Lancet, 1, 675-679.
40. Peterson, B.A., Pajak, T.F., Cooper, M.R., et al. (1982) "Effect of age on therapeutic response and survival in advanced Hodgkin's disease", Cancer Treat. Rep., 66, 889-898.
41. Lokich, J.J., Pinkus, G.S. and Moloney, W.C. (1974) "Hodgkin's disease in the elderly", Oncology, 29, 484-500.
42. Longo, D.L., Young, R.C., Wesley, M. et al. (1986) "Twenty years of MOPP therapy for Hodgkin's disease", J. Clin. Oncol., 4, 1295-1306.
43. Gobbi, P.G., Comelli, M., Grignani, G.E., et al. (1994) "Estimate of expected survival at diagnosis in Hodgkin's disease: a means of weighting prognostic factors and a tool for treatment choice and clinical research. A report from the International Database on Hodgkin's Disease (IDHD)", Haematologica, 79, 241-255.
44. Tubiana, M., Henry-Amar, M., Werf-Messing, B., et al. (1985) "A multivariate analysis of prognostic factors in early stage Hodgkin's disease, Int. J. Radiat. Oncol. Biol. Phys., 11, 23-30.
45. Munker, R., Hasenclever, D., Brosteann, O., et al. (1995) "Bone marrow involvement in Hodgkin's disease: An analysis of 135 consecutive cases", J. Clin. Oncol., 13, 403-409.
46. Carde, P., MacKintosh, F.R. and Rosenberg, S.A. (1983) "A dose and time response analysis of the treatment of Hodgkin's disease with MOPP chemotherapy", J. Clin. Oncol., 1, 146-150.
47. Bonadona, G., Valagussa, P. and Santoro, A. (1986) "Alternating non-cross-resistant combination chemotherapy or MOPP in stage IV Hodgkin's disease", Ann. Intern. Med., 104, 739-746.
48. Straus, D.J., Gaynor, J.J., Myers, J., et al. (1990) "Prognostic factors among 185 adults with newly diagnosed advanced Hodgkin's disease treated with alternating potentially noncross-resistant chemotherapy and intermediate-dose radiation therapy", J. Clin. Oncol., 8, 1173-1186.
49. Selby, P., Patel, P., Milan, S., et al. (1990) ChlVPP combination chemotherapy for Hodgkin's disease: long term results", Br. J. Cancer, 62, 279-285.
50. Pillai, G.N., Hagemeister, F.B., Velasquez, W.S., et al. (1985) "Prognostic factors for stage IV Hodgkin's disease treated with MOPP, with or without bleomycin", Cancer, 55, 691-697.
51. Fermé, C., Bastión, Y., Brice, P., et al. (1997) "Prognosis of patients with advanced Hodgkin's disease: evaluation of four prognostic models using 344 patients included in the Groupe d'Études des Lymphomes de l'Adulte Study", Cancer, 80, 1124-1133.
52. Jaffe, H.S., Cadman, E.C., Farber, L.R., and Bertino, J.R. (1986) "Pretreatment hematocrit as an independent prognostic variable in Hodgkin's disease", Blood, 68, 562-565.
53. Luoni, M., Fava, S. and Declich, P. (1996) "Bone marrow biopsy for staging Hodgkin's lymphoma: the value of bilateral or unilateral trephine biopsy", J. Clin. Oncol., 14, 682-683.
54. Myers, C.E., Chabner, B.A., De Vita, V.T., et al. (1974) "Bone marrow involvement in Hodgkin's disease: Pathology and response to MOPP chemotherapy", Blood, 44, 197-204.
55. O'Carroll, D., McKenna, R.W. and Brunning, R.D. (1976) "Bone marrow manifestations of Hodgkin's disease", Cancer 38, 1717-1728.
56. Ellis, M.E., Diehl, L.F., Granger, E., et al. (1989) "Trephine needle bone marrow biopsy in the initial staging of Hodgkin's disease: Sensitivity and specificity of the Ann Arbor staging procedure criteria", Am. J. Hematol., 30, 115-120.
57. Spech, T.L. and Nissen, N.I. (1988) "Prognostic factors in Hodgkin's disease stage IV", Eur. J. Haematol., 41, 359-367.
58. Rosenberg, S.A. (1971) "Hodgkin's disease of the bone marrow, Cancer Res., 31, 1733-1736.